Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-40421-z, published online 07 March 2019
In the Supplementary Information file originally published with this Article, Supplementary Figures (Figures S1–7) and Supplementary Tables (Tables S1–4) were omitted. These errors have been corrected in the Supplementary Information that now accompanies the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Takizawa, H., Hara, Y., Mizobe, Y. et al. Publisher Correction: Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride. Sci Rep 10, 2462 (2020). https://doi.org/10.1038/s41598-020-59351-2
Published:
DOI: https://doi.org/10.1038/s41598-020-59351-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
